BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9923600)

  • 21. The HIV-1 Env protein signal sequence retards its cleavage and down-regulates the glycoprotein folding.
    Li Y; Luo L; Thomas DY; Kang CY
    Virology; 2000 Jul; 272(2):417-28. PubMed ID: 10873786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological analysis of human immunodeficiency virus type 1 envelope glycoprotein proteolytic cleavage.
    Fenouillet E; Gluckman JC
    Virology; 1992 Apr; 187(2):825-8. PubMed ID: 1372142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stable expression of the human immunodeficiency virus type 1 envelope glycoprotein in transfected L cells.
    Bird C; Gleeson PA; Ramsay A; Li P; McCluskey J
    AIDS Res Hum Retroviruses; 1992 Dec; 8(12):1999-2009. PubMed ID: 1493050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced proteolytic processing of the human immunodeficiency virus type 1 envelope protein in murine Ltk(-) cells.
    Rodriguez D; Rodriguez JR; Esteban M
    AIDS Res Hum Retroviruses; 1995 Jan; 11(1):81-5. PubMed ID: 7734199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The N-terminal 31 amino acids of human immunodeficiency virus type 1 envelope protein gp120 contain a potential gp41 contact site.
    Ivey-Hoyle M; Clark RK; Rosenberg M
    J Virol; 1991 May; 65(5):2682-5. PubMed ID: 2016774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of membrane anchorage domains of the HIV-1 gp160 envelope glycoprotein precursor.
    Gabuzda D; Olshevsky U; Bertani P; Haseltine WA; Sodroski J
    J Acquir Immune Defic Syndr (1988); 1991; 4(1):34-40. PubMed ID: 1984054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expression.
    Bültmann A; Muranyi W; Seed B; Haas J
    J Virol; 2001 Jun; 75(11):5263-76. PubMed ID: 11333908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
    Welman M; Lemay G; Cohen EA
    Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subunit stoichiometry of human immunodeficiency virus type 1 envelope glycoprotein trimers during virus entry into host cells.
    Yang X; Kurteva S; Ren X; Lee S; Sodroski J
    J Virol; 2006 May; 80(9):4388-95. PubMed ID: 16611898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intramolecular quality control: HIV-1 envelope gp160 signal-peptide cleavage as a functional folding checkpoint.
    McCaul N; Quandte M; Bontjer I; van Zadelhoff G; Land A; Crooks ET; Binley JM; Sanders RW; Braakman I
    Cell Rep; 2021 Aug; 36(9):109646. PubMed ID: 34469718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Legitimate and illegitimate cleavage of human immunodeficiency virus glycoproteins by furin.
    Morikawa Y; Barsov E; Jones I
    J Virol; 1993 Jun; 67(6):3601-4. PubMed ID: 8497067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Processing and routage of HIV glycoproteins by furin to the cell surface.
    Moulard M; Hallenberger S; Garten W; Klenk HD
    Virus Res; 1999 Mar; 60(1):55-65. PubMed ID: 10225274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
    Fenouillet E; Miquelis R; Drillien R
    Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maturation of HIV envelope glycoprotein precursors by cellular endoproteases.
    Moulard M; Decroly E
    Biochim Biophys Acta; 2000 Nov; 1469(3):121-32. PubMed ID: 11063880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The membrane-spanning domain of gp41 plays a critical role in intracellular trafficking of the HIV envelope protein.
    Miyauchi K; Curran AR; Long Y; Kondo N; Iwamoto A; Engelman DM; Matsuda Z
    Retrovirology; 2010 Nov; 7():95. PubMed ID: 21073746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-1 gp41 contains two sites for interaction with several proteins on the helper T-lymphoid cell line, H9.
    Chen YH; Ebenbichler C; Vornhagen R; Schulz TF; Steindl F; Böck G; Katinger H; Dierich MP
    AIDS; 1992 Jun; 6(6):533-9. PubMed ID: 1388873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160.
    Freed EO; Myers DJ; Risser R
    J Virol; 1989 Nov; 63(11):4670-5. PubMed ID: 2677400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins.
    Neurath AR; Strick N; Li YY; Jiang S
    AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1195-208. PubMed ID: 8142138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Furin is important but not essential for the proteolytic maturation of gp160 of HIV-1.
    Gu M; Rappaport J; Leppla SH
    FEBS Lett; 1995 May; 365(1):95-7. PubMed ID: 7774724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Processing protease for gp160 human immunodeficiency virus type I envelope glycoprotein precursor in human T4+ lymphocytes. Purification and characterization.
    Kido H; Kamoshita K; Fukutomi A; Katunuma N
    J Biol Chem; 1993 Jun; 268(18):13406-13. PubMed ID: 8099909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.